FDA: New Variants Mean COVID-19 Vaccines, Tests May Need Tweaking

TUESDAY, Feb. 23, 2021 -- The emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants could require a quick pivot on the part of pharmaceutical and medical device companies to help stay one step ahead of COVID-19. The...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news